TFRC and cancer: The results showed that T7 peptide-modified nanoparticles achieved improved cellular uptake, particularly in cancer cells with high TfR expression, in the following order: MDA-MB-231 breast cancer cells > SKOV-3 ovarian cancer cells > U87-MG glioma cells [34].